Alzheimer's Disease Fact Sheet

Anyone with Alzheimer's disease or MCI, and healthy volunteers with or without a family history of Alzheimer's disease, can participate in clinical trials and research. Participants in Alzheimer's clinical trials will help scientists understand the brain's changes in healthy aging and Alzheimer's disease. Currently, it is required that at least 70,000 volunteers participate in over 150 active clinical trials and trials testing methods for understanding, diagnosing, treating and preventing Alzheimer's disease .

Participation in clinical trials will help fight Alzheimer's disease. The study requires participants of different age, sex, race and ethnicity to ensure that the results are meaningful to many people

The National Institute of Aging (NIA) of the National Institute of Health (NIH) is leading the federal government's research on Alzheimer's disease. Alzheimer's Disease Center, supported by NAI in the United States, is conducting extensive research including pathogenesis, diagnosis and treatment of Alzheimer's disease. NIA is also sponsoring the Alzheimer's Disease Cooperative Study (ADCS), a consortium of leading researchers in the United States and Canada, which is conducting clinical trials.

Search ADEAR Center Clinical Trial Finder for a test near you or register for an email alert about the new exam

Register your registration form (such as Alzheimer's Prevention Registry) or matching service (such as TrialMatch) and invite participation in the exam.

Introduction of Alzheimer's Disease Alzheimer's disease (AD) is the most common cause of dementia in the elderly. Dementia is a disease that destroys the manner in which the brain works. AD affects the mind, memory, and brain parts of the language. Scientists know more about AD every day, but the cause of this disease is yet to be known and there is no cure. It is estimated that 4 million people suffer from AD in the United States. This disease usually develops after age 65, and the risk of AD increases with age. Young people may also suffer from AD, but they are not so common. Approximately 3% of men and women aged 65 to 74 suffer from AD, and nearly half of those over 85 years suffer from this disease. However, it is important to note that AD is not a normal part of aging. Scientists also discovered other changes in the brains of AD patients. Loss of nerve cells in the brain area is important for memory and other mental abilities. AD starts slowly

Alzheimer's disease is the most common dementia of people over the age of 65. In fact, the Alzheimer's Association published a report on facts and data on Alzheimer's disease in 2018. One of the main findings is that there are currently approximately 5.7 million people with Alzheimer's disease in the United States. By 2050, this number is expected to reach about 13.8 million Americans (Alzheimer's Association, 2018). The causes of dementia caused by Alzheimer's disease, risk factors and symptoms are somewhat different from other forms of dementia. For AD, this disease first attacks the memory center of the brain.